SynthesisInternational urology and nephrology2023

The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease: a systematic review and meta-analysis.

Congyuan Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.